Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918866 · ClinicalTrials.gov registry record · Phase 4
A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT00918866: Completed Phase 4 study, sponsored by Lantheus Medical Imaging.
NCT00918866 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 32 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00918866, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this clinical research is to learn if DEFINITY® 416 will cause any adverse effects during Right Heart Catheterization. This research was requested by the FDA.
Primary Outcome
Percent change in pulmonary atery pressure change from immediately pre-dose to 31 - 35 minutes post dose
Interventions
- DRUG Definity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
What the finished NCT00918866 record still lists
NCT00918866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Definity is the first listed.
NCT00918866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00918866 about?
NCT00918866 is a clinical study titled "A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure". The purpose of this clinical research is to learn if DEFINITY® 416 will cause any adverse effects during Right Heart Catheterization. This research was requested by the FDA.
What is the current status of trial NCT00918866?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2009-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00918866?
The interventions under investigation include: Definity (DRUG).
Who is sponsoring clinical trial NCT00918866?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00918866's enrollment target sits among peer trials
32 1534th of 2000 higher than 457 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia